April 13, 2021

This article describes the creation of a clinical trial protocol to address the comparatively smaller numbers of Black patients who participate in clinical trials. The researchers note that people of color do not participate in clinical trials as often as white people and that the best way to encourage them to do so is not...

Stand Up To Cancer (SU2C) is an initiative to improve the participation of Black, Indigenous, and People of Color (BIPOC) in cancer clinical trials. The SU2C team consists of doctors and scientists from four New York City institutions specializing in social science and clinical research. This team is a central component of SU2C’s Health Equity...

It is essential that the lack of racial and ethnic diversity in prostate cancer clinical trials be addressed to improve health disparities in racial/ethnic minority populations. This study suggests that population-based cancer registries could be used as a source for recruiting minority patients to overcome problems with diversity and inclusion in clinical trial research. In...

In this MD Newsline exclusive interview, internist/HIV specialist Dr. Pete Thomas and resident physician/public health professional Dr. Janelle Hadley sit down to discuss cultural competence and how to provide culturally competent care. Dr. Pete Thomas: What is cultural competency and what role does it play in your practice? How do doctors gauge and earn a patient’s...

In this MD Newsline exclusive interview, internist/HIV specialist Dr. Pete Thomas sits down for an interview with resident physician/public health professional Dr. Janelle Hadley to discuss HIV treatment over the years and the HIV care continuum. Dr. Janelle Hadley: Can you speak on how HIV treatment has changed over the years? Dr. Pete Thomas: “When I...